Ascendis Pharma Stock Performance
as on September 11, 2026 at 6:59 am IST
Day's Low
Day's High
$259.05$262.17
0.68%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
$186.05$282.1528.67%
Downside
8.17%
Upside
Ascendis Pharma share price movements today
- Previous Close
- $260.81
- Open
- $259.85
- Volume
- 428.1K
- Market Cap
- $17.7B
- Day's Low - High
- $259.05 - $262.17
- 52 Week Low - High
- $186.05 - $282.15
Ascendis Pharma Historical Returns
- 1 Month Return
- + 2.03 %
- 3 Month Return
- + 24.32 %
- 1 Year Return
- + 31.42 %
- 3 Year Return
- + 167.28 %
- 5 Year Return
- + 68.87 %
Ascendis Pharma Stock Fundamentals & Key Indicators
Check Ascendis Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$17.7B
EPS (TTM)
12.1
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
18.53
Industry PE ratio
10.26
PEG Ratio
0.02943837580987714
EBITDA
78.1M
Revenue (TTM)
1.1B
Profit Margin
90.19%
Return On Equity TTM
190.44%
Ascendis Pharma Stock Valuation
Track how Ascendis Pharma P/E has moved over time to understand its valuation trends.
Ascendis Pharma in the last 5 years
Lowest (-50.13x)
December 31, 2025
Today (-50.13x)
December 31, 2025
Industry (10.26x)
December 31, 2025
Highest (-10.97x)
December 31, 2022
Today’s Price to Earnings Ratio: -50.13x
Ascendis Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ascendis Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $17.7B | 68.87% | 18.53 | 90.19% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 181.2% | 30.54 | 86.04% | NA | |
| BUY | $56.0B | -69.82% | -16.99 | -12.57% | NA | |
| BUY | $85.2B | 24.16% | 19.28 | 84.86% | 45.660000000000004% |
Stock Returns calculator for Ascendis Pharma Stock including INR - Dollar returns
The Ascendis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Ascendis Pharma investment value today
Current value as on today
₹1,42,437
Returns
₹42,437
(+42.44%)
Returns from Ascendis Pharma Stock
₹31,427 (+31.43%)
Dollar Impact
₹11,010 (+11.01%)
Analyst Recommendation on Ascendis Pharma Stock
Based on 17 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 17 analysts, 100% of analysts recommend a 'BUY' rating for Ascendis Pharma. Average target price of $315.25
Ascendis Pharma Share Price Target
Get share price movements and forecasts by analysts on Ascendis Pharma.
What analysts predicted
17.26%UPSIDE
Target Price
$315.25
Current Price
$260.83
Analyzed by
17 Analysts
Target
$315.25
Ascendis Pharma target price $315.25, a slight upside of 17.26% compared to current price of $260.83. According to 17 analysts rating.
Indian Investors' Interest in Ascendis Pharma Stock
Search interest for Ascendis Pharma Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:126% versus previous 30 day period
Ascendis Pharma Quarterly Profit & Loss
All numbers in Millions USD
Ascendis Pharma Annual Profit & Loss
All numbers in Millions USD
Ascendis Pharma Quarterly Cash Flow
All numbers in Millions USD
Ascendis Pharma Annual Cash Flow
All numbers in Millions USD
Ascendis Pharma News & Key Events
Today's Timeline - 09 September
Thu, 01:42 AM
-Ascendis Pharma reports positive Week 52 data from reACHin Trial for TransCon CNP in infants with achondroplasia.
Thu, 01:58 AM
-Ascendis Pharma grants employee warrants and updates capital structure, allowing for future equity issuance.
Thu, 03:17 AM
-Ascendis Pharma presents Week 52 data showing positive growth outcomes and safety profile for TransCon CNP.
Insights on Ascendis Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 6 quarters, 100.95M → 344.90M (in $), with an average increase of 20.9% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ASND has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, ASND stock has moved up by 21.0%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 434.1% return, outperforming this stock by 402.2%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 639.68M → 210.39M (in $), with an average decrease of 67.1% per quarter
About Ascendis Pharma
| Organisation | Ascendis Pharma |
| Headquarters | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
| Industry | Biotechnology |
| CEO | Mr. Jan Moller Mikkelsen |
| E-voting on shares | Click here to vote |
Key Management of Ascendis Pharma
Name | Title |
|---|---|
Ms. Pedersen Anni Lotte Kirstine Sonderbjerg | Executive VP, Chief Administrative Officer & Member of the Executive Board |
Mr. Flemming Steen Jensen | Executive Vice President of Product Supply & Quality |
Dr. Kennett Sprogoe Ph.D. | Executive VP and Head of Research & Product Development |
Mr. Jan Moller Mikkelsen | President, CEO, Member of Executive Board & Executive Director |
Mr. Scott T. Smith | CFO, Executive VP & Member of Executive Board |
Mr. Chad Fugure | Vice President of Investor Relations |
Mr. Joseph Kelly | Head of U.S. Commercial of Endocrinology |
Ms. Sherrie Lynn Glass | Chief Business Officer |
Mr. Michael Wolff Jensen L.L.M. | Executive VP, Chief Legal Officer & Member of the Executive Board |
Mr. Mads Bodenhoff | Senior VP, Head of Finance & Principal Accounting Officer |
FAQs
What is Ascendis Pharma share price today?
Ascendis Pharma share price today is $260.83 as on at the close of the market. Ascendis Pharma share today touched a day high of $262.17 and a low of $259.05.
What is the 52 week high and 52 week low for Ascendis Pharma share?
Ascendis Pharma share touched a 52 week high of $282.15 on and a 52 week low of $186.05 on . Ascendis Pharma stock price today i.e. is closed at $260.83,which is 7.56% down from its 52 week high and 40.19% up from its 52 week low.
What is Ascendis Pharma's market capitalisation today?
Ascendis Pharma market capitalisation is $0.02T as on .
How to invest in Ascendis Pharma Stock (ASND) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ascendis Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ascendis Pharma Shares that will get you 0.0058 shares as per Ascendis Pharma share price of $260.83 per share as on September 11, 2026 at 1:29 am IST.
What is the minimum amount required to buy Ascendis Pharma Stock (ASND) from India?
Indian investors can start investing in Ascendis Pharma (ASND) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Ascendis Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ascendis Pharma share’s latest price of $260.83 as on September 11, 2026 at 1:29 am IST, you will get 0.0383 shares of Ascendis Pharma. Learn more about
fractional shares .
What are the returns that Ascendis Pharma has given to Indian investors in the last 5 years?
Ascendis Pharma stock has given 68.87% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?